Internal Medicine, Geriatric Medicine · Edison, NJ
NPI
1487688586
Since 2006
Specialty
Internal Medicine, Geriatric Medicine
Code 207RG0300X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2149 Woodbridge Ave
Edison, NJ, 08817
Phone (732) 985-2151
Groups this clinician bills Medicare through
Medicare paid, 2024
$217K
3,000 services
Medicare patients, 2024
445
Average age 77
Drug cost, 2024
$3.8M
26,053 prescriptions
Company payments, 2025
$643
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ketankumar N Vaidya was code 99214 (office e&m - established), 1,054 times for 324 patients. In total Ketankumar N Vaidya billed 3,000 services in 32 codes, and Medicare paid $217K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,054 | 324 | $92.70 | $98K |
| 99213 Office E&M - Established | Office | 489 | 215 | $61.61 | $30K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 304 | 177 | $12.76 | $3,878 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 272 | 272 | $140.64 | $38K |
| 99307 SNF E&M | Facility | 194 | 56 | $34.31 | $6,656 |
| 99457 E&M - Miscellaneous | Office | 159 | 21 | $40.90 | $6,503 |
| 99454 E&M - Miscellaneous | Office | 75 | 12 | $42.64 | $3,198 |
| 93000 Electrocardiogram | Office | 54 | 50 | $11.17 | $603 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 43 | 43 | $20.74 | $892 |
| 99304 SNF E&M | Facility | 37 | 32 | $68.05 | $2,518 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 35 | 29 | $245.14 | $8,580 |
| 99349 Home E&M - New and Established | Office | 28 | 23 | $97.48 | $2,729 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 19 | 19 | $179.49 | $3,410 |
| 99203 Office E&M - New | Office | 18 | 18 | $62.72 | $1,129 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 17 | 16 | $172.91 | $2,939 |
By year: 2022 $169K for 3,071 services; 2023 $153K for 2,734 services; 2024 $217K for 3,000 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ketankumar N Vaidya prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,763 prescriptions and refills. In total Ketankumar N Vaidya wrote 26,053 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,763 | 3,480 | 380 | $14K |
| Levothyroxine Sodium Generic | 1,228 | 2,282 | 220 | $12K |
| Metformin Hcl Generic | 932 | 1,914 | 211 | $5,793 |
| Amlodipine Besylate Generic | 882 | 1,670 | 198 | $4,973 |
| Losartan Potassium Generic | 799 | 1,516 | 168 | $6,503 |
| Pantoprazole Sodium Generic | 747 | 1,335 | 189 | $6,531 |
| Diclofenac Sodium Generic | 605 | 866 | 150 | $406K |
| Gabapentin Generic | 543 | 722 | 99 | $8,116 |
| Metoprolol Succinate Generic | 525 | 1,090 | 123 | $6,675 |
| Eliquis Apixaban | 434 | 474 | 63 | $230K |
| Lisinopril Generic | 422 | 840 | 93 | $2,939 |
| Metoprolol Tartrate Generic | 416 | 675 | 86 | $2,575 |
| Omeprazole Generic | 415 | 740 | 91 | $4,272 |
| Simvastatin Generic | 389 | 771 | 78 | $3,005 |
| Tamsulosin Hcl Generic | 378 | 649 | 79 | $4,224 |
Brand drugs: 4,823 claims; generic drugs: 20,916 claims; opioid claims: 168.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ketankumar N Vaidya $643 ($643 in general payments such as food, travel and fees) from 10 companies. The largest payer was Dexcom, Inc. with $164.
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. DXCM | 5 | $164 |
| Abbvie Inc. ABBV | 13 | $153 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $61.95 |
| Exact Sciences Corporation EXAS | 3 | $60.18 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $48.03 |
| Lilly USA, LLC LLY | 3 | $47.69 |
| Merck Sharp & Dohme LLC MRK | 3 | $45.11 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $31.12 |
| Eisai Inc. 4523.T | 1 | $17.43 |
| Amgen Inc. AMGN | 1 | $15.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.